Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.

Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV.

Clin Oncol (R Coll Radiol). 2010 May;22(4):281-8. doi: 10.1016/j.clon.2010.02.001. Epub 2010 Feb 26.

PMID:
20189371
4.

Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.

Brochu M, Mathieu ME, Karelis AD, Doucet E, Lavoie ME, Garrel D, Rabasa-Lhoret R.

Obesity (Silver Spring). 2008 May;16(5):1085-93. doi: 10.1038/oby.2008.23. Epub 2008 Feb 28.

6.

Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.

Santos AC, Lopes C, Guimarães JT, Barros H.

Int J Obes (Lond). 2005 Dec;29(12):1452-6.

PMID:
16077717
7.

Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women.

Karelis AD, Henry JF, St-Pierre DH, Prud'homme D, Rabasa-Lhoret R.

Diabetes Obes Metab. 2006 May;8(3):336-41.

PMID:
16634994
8.

SHBG levels correlate with insulin resistance in postmenopausal women.

Akin F, Bastemir M, Alkiş E, Kaptanoglu B.

Eur J Intern Med. 2009 Mar;20(2):162-7. doi: 10.1016/j.ejim.2007.09.023. Epub 2008 Jul 30.

PMID:
19327605
9.

Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity.

Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M.

Metab Syndr Relat Disord. 2009 Oct;7(5):447-52. doi: 10.1089/met.2008.0100.

PMID:
19419266
10.

Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I.

J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60.

PMID:
15292387
11.

Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.

Petri Nahas EA, Padoani NP, Nahas-Neto J, Orsatti FL, Tardivo AP, Dias R.

Climacteric. 2009 Oct;12(5):431-8. doi: 10.1080/13697130902718168.

PMID:
19415539
12.

Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.

González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O.

Eur J Clin Nutr. 2006 Jun;60(6):802-9. Epub 2006 Feb 22.

PMID:
16493453
13.

The association of metabolic syndrome with triple-negative breast cancer.

Maiti B, Kundranda MN, Spiro TP, Daw HA.

Breast Cancer Res Treat. 2010 Jun;121(2):479-83. doi: 10.1007/s10549-009-0591-y. Epub 2009 Oct 23.

PMID:
19851862
14.

C-reactive protein is elevated in obese patients with the metabolic syndrome.

Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R.

Diabetes Res Clin Pract. 2006 Jan;71(1):92-100. Epub 2005 Jul 5.

PMID:
16002176
15.

Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.

Malita FM, Messier V, Lavoie JM, Bastard JP, Rabasa-Lhoret R, Karelis AD.

Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):173-9. doi: 10.1016/j.numecd.2009.03.005. Epub 2009 Jun 5.

PMID:
19501492
16.

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.

Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, De Marco M, Cavalcanti E, D'Aiuto M, Fucito A, Frasci G, Maurea N, Esposito G, Pedicini T, Vecchione A, D'Aiuto G, Giordano A.

Cancer Biol Ther. 2010 Dec 15;10(12):1240-3. Epub 2010 Dec 15.

PMID:
20935521
17.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
18.

Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial.

Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan KB, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A.

Obes Res. 2005 Mar;13(3):615-25.

19.

A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA, Rohan TE.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53. doi: 10.1158/1055-9965.EPI-09-0235. Epub 2009 Jun 30.

20.

Change in plasma acylation stimulating protein during euglycaemic-hyperinsulinaemic clamp in overweight and obese postmenopausal women: a MONET study.

St-Pierre DH, Cianflone K, Smith J, Coderre L, Karelis AD, Imbeault P, Lavoie JM, Rabasa-Lhoret R.

Clin Endocrinol (Oxf). 2009 Apr;70(4):539-46. doi: 10.1111/j.1365-2265.2008.03353.x. Epub 2008 Aug 13.

PMID:
18702682

Supplemental Content

Support Center